SCHEMBL1134441

SCHEMBL1134441

CCCOCC1CCCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA4 P22748 5/20 0.41
CA6 P23280 4/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP2D6 P10635 1/20 0.34
PTGS1 P23219 2/20 0.33
PTGS2 P35354 2/20 0.33
OPRK1 P41145 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27506837 0.95 CA1 (0.36) CA1CA2CA4CA6NPC1
SCHEMBL25160054 0.86 SMN1; SMN2 (0.43) CA1CA2CA4CA6NPC1
SCHEMBL3437946 0.77 CA1 (0.49) CA1CA2CA4CA6NPC1
SCHEMBL8615642 0.75 NPC1 (0.46) CA1CA2CA4CA6NPC1
SCHEMBL12870052 0.75 NPC1 (0.51) CA1CA2CA4CA6NPC1
SCHEMBL420230 0.75 NPC1 (0.51) CA1CA2CA4CA6NPC1
SCHEMBL4989431 0.75 CA1 (0.38) CA1CA2CA4CA6NPC1
SCHEMBL200410 0.74
SCHEMBL3370 0.74 ALDH1A1 (0.39) CA1CA2CA4CA6NPC1
SCHEMBL11010393 0.73 NPC1 (0.42) CA1CA2CA4CA6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285798-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA AstraZeneca AB (SE) 2011-02-23 EP disclosed
WO-2009136850-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA ASTRAZENECA AB (SE) 2009-11-12 WO disclosed